Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism
- PMID: 558741
- DOI: 10.1001/archpsyc.1977.01770170063005
Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism
Abstract
The sympathetic nervous system was evaluated in 11 primary autistic patients and their families. The plasma levels of norepinephrine (NE), the neurotransmitter of the sympathetic nervous system, was higher in the patients than in age-controlled normal volunteers both while supine and after standing. The plasma activity of dopamine-beta-hydroxylase, the enzyme that converts dopamine to NE, was significantly lower in the autistic patients and their healthy relatives than in control groups. Dopamine-beta-hydroxylase does not appear to provide an index of sympathetic activity in this group of patients who, on the basis of the elevated plasma levels of NE, may demonstrate a chronic state of hyperactivity of the sympathetic nervous system. Low enzyme activity found in both the autistic patients and their immediate families may be associated with this disorder.
Similar articles
-
Catecholamine metabolism in Gilles de la Tourette's syndrome.Am J Psychiatry. 1977 Mar;134(3):257-60. doi: 10.1176/ajp.134.3.257. Am J Psychiatry. 1977. PMID: 265141
-
Significance of plasma dopamine beta-hydroxylase activity as an index of sympathetic neuronal function.Proc Natl Acad Sci U S A. 1974 Nov;71(11):4392-4. doi: 10.1073/pnas.71.11.4392. Proc Natl Acad Sci U S A. 1974. PMID: 4530990 Free PMC article.
-
Platelet monoamine oxidase in early childhood autism.Arch Gen Psychiatry. 1977 May;34(5):534-7. doi: 10.1001/archpsyc.1977.01770170044003. Arch Gen Psychiatry. 1977. PMID: 871232
-
Clinical neurochemistry of autism and associated disorders.J Autism Dev Disord. 1982 Jun;12(2):147-65. doi: 10.1007/BF01531305. J Autism Dev Disord. 1982. PMID: 6184361 Review.
-
[From gene to disease; dopamine-beta-hydroxylase deficiency and orthostatic hypotension].Ned Tijdschr Geneeskd. 2004 Sep 4;148(36):1771-5. Ned Tijdschr Geneeskd. 2004. PMID: 15495941 Review. Dutch.
Cited by
-
The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.Semin Pediatr Neurol. 2020 Oct;35:100834. doi: 10.1016/j.spen.2020.100834. Epub 2020 Jun 24. Semin Pediatr Neurol. 2020. PMID: 32892961 Free PMC article. Review.
-
Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism.J Autism Dev Disord. 1992 Jun;22(2):295-308. doi: 10.1007/BF01058157. J Autism Dev Disord. 1992. PMID: 1624410
-
Growth hormone response to L-dopa and clonidine in autistic children.J Autism Dev Disord. 1990 Dec;20(4):455-65. doi: 10.1007/BF02216052. J Autism Dev Disord. 1990. PMID: 2279968
-
Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.Front Cell Neurosci. 2018 Nov 20;12:422. doi: 10.3389/fncel.2018.00422. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30524240 Free PMC article. Review.
-
Speech-Stimulating Substances in Autism Spectrum Disorders.Behav Sci (Basel). 2019 Jun 12;9(6):60. doi: 10.3390/bs9060060. Behav Sci (Basel). 2019. PMID: 31212856 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources